Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
Uploaded 2 months ago
Duration: 0h 5m 5s
Wockhardt exits US generics biz, to focus on innovation
Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations.
The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.
Uploaded by: Rediff Video Desk on Sat, 12 Jul 2025 22:25:35 +0530
Views: 95
Tags: Wockhardt exits US generics biz, to focus on innovation
© 2025